» Articles » PMID: 35583003

Multifaceted Regulation and Functions of 53BP1 in NHEJ‑mediated DSB Repair (Review)

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2022 May 18
PMID 35583003
Authors
Affiliations
Soon will be listed here.
Abstract

The repair of DNA double‑strand breaks (DSBs) is crucial for the preservation of genomic integrity and the maintenance of cellular homeostasis. Non‑homologous DNA end joining (NHEJ) is the predominant repair mechanism for any type of DNA DSB during the majority of the cell cycle. NHEJ defects regulate tumor sensitivity to ionizing radiation and anti‑neoplastic agents, resulting in immunodeficiencies and developmental abnormalities in malignant cells. p53‑binding protein 1 (53BP1) is a key mediator involved in DSB repair, which functions to maintain a balance in the repair pathway choices and in preserving genomic stability. 53BP1 promotes DSB repair via NHEJ and antagonizes DNA end overhang resection. At present, novel lines of evidence have revealed the molecular mechanisms underlying the recruitment of 53BP1 and DNA break‑responsive effectors to DSB sites, and the promotion of NHEJ‑mediated DSB repair via 53BP1, while preventing homologous recombination. In the present review article, recent advances made in the elucidation of the structural and functional characteristics of 53BP1, the mechanisms of 53BP1 recruitment and interaction with the reshaping of the chromatin architecture around DSB sites, the post‑transcriptional modifications of 53BP1, and the up‑ and downstream pathways of 53BP1 are discussed. The present review article also focuses on the application perspectives, current challenges and future directions of 53BP1 research.

Citing Articles

CHAMP1 premature termination codon mutations found in individuals with intellectual disability cause a homologous recombination defect through haploinsufficiency.

Yoshizaki Y, Ouchi Y, Kurniawan D, Yumoto E, Yoneyama Y, Rizqullah F Sci Rep. 2024; 14(1):31904.

PMID: 39738383 PMC: 11686235. DOI: 10.1038/s41598-024-83435-y.


The Potential of Plant Polysaccharides and Chemotherapeutic Drug Combinations in the Suppression of Breast Cancer.

Adewale O, Winska P, Piasek A, Ciesla J Int J Mol Sci. 2024; 25(22).

PMID: 39596268 PMC: 11594611. DOI: 10.3390/ijms252212202.


PARP inhibitors in prostate cancer: clinical applications.

Saeidi H, Sarafbidabad M Mol Biol Rep. 2024; 51(1):1103.

PMID: 39476131 DOI: 10.1007/s11033-024-10034-5.


NEAT1 modulates the TIRR/53BP1 complex to maintain genome integrity.

Kilgas S, Syed A, Toolan-Kerr P, Swift M, Roychoudhury S, Sarkar A Nat Commun. 2024; 15(1):8438.

PMID: 39349456 PMC: 11443056. DOI: 10.1038/s41467-024-52862-w.


Molecular mechanism of PARP inhibitor resistance.

Huang Y, Chen S, Yao N, Lin S, Zhang J, Xu C Oncoscience. 2024; 11:69-91.

PMID: 39318358 PMC: 11420906. DOI: 10.18632/oncoscience.610.


References
1.
Campillo-Marcos I, Garcia-Gonzalez R, Navarro-Carrasco E, Lazo P . The human VRK1 chromatin kinase in cancer biology. Cancer Lett. 2021; 503:117-128. DOI: 10.1016/j.canlet.2020.12.032. View

2.
Clements K, Schleicher E, Thakar T, Hale A, Dhoonmoon A, Tolman N . Identification of regulators of poly-ADP-ribose polymerase inhibitor response through complementary CRISPR knockout and activation screens. Nat Commun. 2020; 11(1):6118. PMC: 7704667. DOI: 10.1038/s41467-020-19961-w. View

3.
Panier S, Durocher D . Push back to respond better: regulatory inhibition of the DNA double-strand break response. Nat Rev Mol Cell Biol. 2013; 14(10):661-72. DOI: 10.1038/nrm3659. View

4.
Yang X, Xu B, Mulvey B, Evans M, Jordan S, Wang Y . Differentiation of human pluripotent stem cells into neurons or cortical organoids requires transcriptional co-regulation by UTX and 53BP1. Nat Neurosci. 2019; 22(3):362-373. PMC: 6511450. DOI: 10.1038/s41593-018-0328-5. View

5.
Markiewicz-Potoczny M, Lobanova A, Loeb A, Kirak O, Olbrich T, Ruiz S . TRF2-mediated telomere protection is dispensable in pluripotent stem cells. Nature. 2020; 589(7840):110-115. PMC: 9161009. DOI: 10.1038/s41586-020-2959-4. View